Literature DB >> 22390482

PKCθ: a new target for selective immunosuppression.

Amnon Altman, Kok-Fai Kong.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22390482     DOI: 10.1586/eci.12.8

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


× No keyword cloud information.
  7 in total

Review 1.  Back to the future: oral targeted therapy for RA and other autoimmune diseases.

Authors:  John J O'Shea; Arian Laurence; Iain B McInnes
Journal:  Nat Rev Rheumatol       Date:  2013-02-19       Impact factor: 20.543

Review 2.  In and out of the bull's eye: protein kinase Cs in the immunological synapse.

Authors:  Kok-Fai Kong; Amnon Altman
Journal:  Trends Immunol       Date:  2013-02-19       Impact factor: 16.687

3.  Ceramide inhibits PKCθ by regulating its phosphorylation and translocation to lipid rafts in Jurkat cells.

Authors:  Rouba Hage-Sleiman; Asmaa B Hamze; Aimée F El-Hed; Randa Attieh; Lina Kozhaya; Sarah Kabbani; Ghassan Dbaibo
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

Review 4.  Protein kinase C inhibitors for immune disorders.

Authors:  Amnon Altman; Kok-Fai Kong
Journal:  Drug Discov Today       Date:  2014-06-02       Impact factor: 7.851

5.  Regulating the Regulator: Phosphorylation of PKC θ in T Cells.

Authors:  Michael Freeley; Aideen Long
Journal:  Front Immunol       Date:  2012-08-01       Impact factor: 7.561

6.  PKC-theta-mediated signal delivery from the TCR/CD28 surface receptors.

Authors:  Noah Isakov; Amnon Altman
Journal:  Front Immunol       Date:  2012-08-22       Impact factor: 7.561

7.  Cyclic AMP-Responsive Element-Binding Protein (CREB) is Critical in Autoimmunity by Promoting Th17 but Inhibiting Treg Cell Differentiation.

Authors:  Xiaohu Wang; Lu Ni; Dehui Chang; Huiping Lu; Yu Jiang; Byung-Seok Kim; Aibo Wang; Xindong Liu; Bo Zhong; Xuexian Yang; Chen Dong
Journal:  EBioMedicine       Date:  2017-10-12       Impact factor: 8.143

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.